Rare-disease and intensive-care pharma with global operations from Austria
AOP Health manufactures and distributes pharmaceuticals for rare diseases, cardiology, hematology, oncology, and intensive care—operating across 501–1,000 employees worldwide from Vienna. The tech stack (Veeva, SAP, Dynamics 365, Azure) is standard for regulated pharma, but hiring velocity is accelerating around commercial effectiveness and market-access functions, while active projects center on standardizing go-to-market processes, new product launches, and serialization compliance.
Notable leadership hires: Brand Director
AOP Health Group, headquartered in Vienna, has operated since 1996 as a privately held enterprise dedicated to rare diseases and critical-care medicine. The company markets its therapeutic focus across rare disease, cardiology, hematology, oncology, pulmonology, and intensive care through subsidiaries and international partner networks. Operations span manufacturing, warehousing, regulatory compliance, and a commercial organization covering pricing, market access, and sales. The current hiring focus—concentrated in commercial, finance, and ops roles across Austria and Italy—reflects near-term expansion in product launches and international market entry.
Veeva Vault and Veeva (for pharma-specific compliance), SAP and Dynamics 365 (ERP), Jira and Trello (project management), Azure (cloud), and standard Microsoft 365 tools. Stack is typical for regulated pharmaceutical manufacturing.
New product launches, commercial effectiveness standardization, pricing and market-access strategy, international market entry, serialization compliance, and supply-chain optimization (warehouse and transport). These projects address both regulatory requirements and internal process maturity.
Other companies in the same industry, closest in size